Murray Presses FDA Commissioner on Mass Firings, Trump Admin Ripping Away Mifepristone

Today, at a Senate Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Ag-FDA) Subcommittee hearing on the fiscal year 2026 budget request for the Food and Drug Administration (FDA), U.S. Senator Patty Murray (D-WA), Vice Chair of the Senate Appropriations Committee and a senior member and former Chair of the Senate Health, Education, Labor and Pensions (HELP) Committee, grilled FDA Commissioner Marty Makary on the Trump administration’s reckless and chaotic efforts to fire thousands of critical employees FDA, conflicts of interest at the agency, and the Trump administration’s attempts to lay the groundwork to rip away access to mifepristone based on discredited junk science from by anti-abortion activists.